Concepedia

Anna Turkina

AT

56

Publications

3.1K

Citations

25

H-Index

1996

Active since

Affiliations

National Medical Research Center for Hematology(Current)

Federal Almazov North-West Medical Research Centre

The University of Texas MD Anderson Cancer Center

Russian Research Institute of Hematology and Transfusiology

Novartis (Switzerland)

Anna Turkina is an author at National Medical Research Center for Hematology specializing in medicine, oncology, and hematology.

ORCID

Top concepts

Publications per year

1996–2025

56

Publications

56

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Jörge E. Cortes, Hagop M. Kantarjian, Tim H. Brümmendorf et al. · Blood · 2011 · 457 citations

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

Delphine Réa, Michael J. Mauro, Carla Boquimpani et al. · Blood · 2021 · 319 citations · Full text

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

Verena Hoffmann, Michele Baccarani, Joerg Hasford et al. · Leukemia · 2015 · 250 citations · Full text

, , +9

Phase I to II Multicenter Study of Oblimersen Sodium, a Bcl-2 Antisense Oligonucleotide, in Patients With Advanced Chronic Lymphocytic Leukemia

Susan O’Brien, Charles Cunningham, A. Golenkov et al. · Journal of Clinical Oncology · 2005 · 190 citations

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

Jörge E. Cortes, Jane F. Apperley, Elza Lomaia et al. · Blood · 2021 · 185 citations · Full text

Rows per page

1–5 of 56